The Candesartan Adjunctive Depression Trials—CADET

The CADET Trials examine the efficacy of candesartan in reducing depressive symptoms in both unipolar and bipolar depression, and whether its effects are mediated through the renin-angiotensin system. Candesartan is affordable, accessible, and well-tolerated. If effective, it could quickly be adopted into clinical practice as a new adjunctive medication for the treatment of these disorders.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Psychopharmacology
Published
2026-03-13
DOI
https://doi.org/10.1097/jcp.0000000000002156
Primary Topic
Electroconvulsive Therapy Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Candesartan Adjunctive Depression Trials—CADET

J. Kim, A. A. NIERENBERG, Elle Nguyen, Sylvia Chu Lin et al.
Journal of Clinical Psychopharmacology
Electroconvulsive Therapy Studies
article

The Candesartan Adjunctive Depression Trials—CADET

J. Kim, A. A. NIERENBERG, Elle Nguyen, Sylvia Chu Lin, Sarah Croce, John Amerena, Janardhanan C. Narayanaswamy, Stella May Gwini, Joel King, Adam J. Walker, Olivia Dean, Mohammadreza Mohebbi, Steven Moylan, Lana J. Williams, Cas Schrueder, Malcolm Hopwood, Jeremy Couper, Alyna Turner, Paul Cortissos, Jon‐Paul Khoo, Melanie M. Ashton, Jessica Green, Judy Hope, Sammy Russell, John Tiller, Rebecca Corva, Chee H. Ng, Mary Lou Chatterton, Gin S. Malhi, Brisa S. Fernandes, Michael Berk, Andre F. Carvalho, Trisha Suppes, Selin Hikmet, Lars Vedel Kessing, Bradley Matthews, Chun Hui J. Park, Emily Moriarty, Seetal Dodd, Kurukula Sarangi Nanayakkara
article en

Abstract

The CADET Trials examine the efficacy of candesartan in reducing depressive symptoms in both unipolar and bipolar depression, and whether its effects are mediated through the renin-angiotensin system. Candesartan is affordable, accessible, and well-tolerated. If effective, it could quickly be adopted into clinical practice as a new adjunctive medication for the treatment of these disorders.

Journal of Clinical Psychopharmacology
University of Copenhagen (DK), The University of Sydney (AU), Barwon Health (AU), Deakin University (AU), The University of Queensland (AU), The University of Melbourne (AU), VA Palo Alto Health Care System (US), Florey Institute of Neuroscience and Mental Health (AU), Geelong Hospital (AU), St Vincent Hospital (US), Royal North Shore Hospital (AU), The Alfred Hospital (AU), Massachusetts General Hospital (US), Orygen Youth Health (AU), Monash Alfred Psychiatry Research centre (AU), Eastern Health (AU), St Vincent’s Private Hospital Sydney (AU), Ballarat Health Services (AU), Copenhagen Prospective Studies on Asthma in Childhood (DK), St. Vincent Hospital (US), Melbourne Clinic (AU), Alfred Health (AU), National Institute of Mental Health (CZ), Grampians Health, Monash University (AU), Stanford University (US)
Openalex Percentile: Top 31%
Electroconvulsive Therapy Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.